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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
















 Understanding the fundamental 
physiological and immunological 
processes underlying the clinical 
manifestations of COVID-19 is vital 
for the identification and rational 
design of effective therapies 
 Therapies targeting the virus and 
controlling the inflammatory 
response may synergise to block 
pathologies at multiple steps 
 Vaccine development and 
evaluation must note the association 
between immune dysfunction and 
outcome of disease severity in 
patients with COVID-19  
 Further studies identifying markers 
of immune correlates of protection 
will help effective triage of patients 
  
2 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source Description 
30.04.2020 COVID-19 and the Rights of 





28.04.2020 COVI-PREG CHUV   International COVID-19 and 
Pregnancy   Registry 





  Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing compendium 
for low resource settings: a 




Ongoing WHO Country & Technical 
Guidance 
WHO   
Ongoing Rapid guidelines and 
evidence summaries 
NICE   
Ongoing Inter-Agency Standing 
Committee (IASC) 
IASC   
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
28.04.2020 COVID-19 – We urgently need to start 
developing an exit strategy  
Int J Infect Dis | 
Perspective 
Eskild Petersen et 
al. 
30.04.2020 COVID-19’s final frontier: The central 
Africa region 





29.04.2020 Keeping COVID-19 at bay in Africa  Lancet Respir 
Med | News 
Munyaradzi Makoni 
26.04.2020 Interdisciplinary perspective on health 
literacy research around the world: 
more important ever in a time of 
COVID-19 
Int J Environ res 
Public Health | 
Editorial 
Tetine Sentell, 
Sandra Vamos & 
Orkan Okan 
30.04.2020 COVID-19 reveals weak health 
systems by design: why we must re-
make global health in this historic 
moment  
Glob Public Health 
| Commentary 
 Sriram 
Shamasunder et al. 
28.04.2020 Pandemic responses: planning to 
neutralize SARS-CoV-2 and prepare 
for future outbreaks 




01.05.2020 Rolling out mass hydroxychloroquine 
prophylaxis for covid-19 in India’s 
slums risk eroding public trust 
BMJ | Opinion  Eejrenab 
Natnayas, Varsha 
Eknath Gaikwad & 
Yogesh Jain 
04.05.2020 COVID-19 mental-health responses 
neglect social realities 
Nature | World 
View 
Rochelle Burgess 
30.04.2020 Covid-19 and domestic violence: 
Caring states? 
ESID | Blog Sohela Nazneen 
04.05.2020 Covid-19: Confidentiality agreements 
allow antibody test manufacturers to 
withhold evaluation results  
BMJ | News 
 
23.04.2020 COVID-19: A global pandemic 
demands a global response 
Georgetown 
University | White 
paper 
Mark Dybul, Robert 
Morello, J Smart, 
Rebecca Katz & 
Peter Piot et al. 
29.04.2020 5 ways NGOs are working with local 
partners to respond to COVID-19 
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C19 Resource Hubs 















Africa CDC The Lancet LSTM Stop TB 
Partnership 
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WHO Q&A Nigeria 
CDC 
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Cell Press Johns Hopkins 
University 
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UN Women Africa 
Evidence 
Network 
PLoS CMMID Repository     
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of 
Public Health 
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UNHCR     Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF      HEART     
UNESCO   Wiley 
Health 
Economics 
 UKRI     
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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